[Other] Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study

imee Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-22 18:50
Reward10points

  • Shitara K, Rha S, Wyrwicz L et al.
    Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
    The Lancet Oncology, 2023; 25, 212-224



Reply

Use magic Donate Report

All Reply1 Show all posts
Mariazufi17 Post time Half hour(s) ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    9870


Return to the list